Novus Therapeutics, Inc. 4
4 · Novus Therapeutics, Inc. · Filed May 11, 2017
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2017-05-10$9.99/sh+58,959$589,000→ 115,856 total
Footnotes (1)
- [F1]All numbers give effect to the 1:9 reverse stock split effected by the Issuer on May 11, 2017.